South Korea regulators said today that it fined Swiss drugmaker Novartis (NYSE:NVS)$48.8 million for offering doctors kickbacks in exchange for recommending the company’s drugs to patients.
The Ministry of Health and Welfare also decided to suspend insurance coverage of 9 variations of 2 drugs, including the Alzheimer’s drug Exelon, for 6 months, according to Reuters.
Get the full story at our sister site, Drug Delivery Business News.
The post Novartis slapped with $49m fine over kickbacks appeared first on MassDevice.